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In this issue of the Journal, Nielsen et al. (1) report the
results of the first randomized trial comparing the AAIR
and DDDR modes of pacing in 177 consecutive patients
who received a first pacemaker for sick sinus syndrome. The
patients were followed for 2.9  1.1 years and had normal
atrioventricular (AV) conduction (according to previously
used arbitrary criteria by these workers) and no bundle
branch block. The primary end points were changes from
baseline to last follow-up in left atrial (LA) size and left
ventricular (LV) function, as determined by M-mode echo-
cardiography. The patients were randomized to three arms:
AAIR, DDDR-s (short, rate-adaptive AV delay 110 to 150
ms) and DDDR-l (fixed, long AV delay 250 ms) modes.
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The AV delay was not optimized because the study was
designed to evaluate the effect of cumulative right ventric-
ular (RV) pacing. The AAIR group exhibited no significant
change in the LA and LV diameters or LV fractional
shortening (LVFS). However, the LA diameter increased
significantly in both DDDR groups (more marked in the
DDDR-s group), whereas LVFS decreased significantly in
the DDDR-s group but not in the DDDR-l group.
The AAIR versus DDDR trial clearly documents the
detrimental effects of ventricular desynchronization or LV
dyssynchrony produced by long-term, nonphysiologic RV
pacing (1). The DDDR-s group with 90% proportion of
RV pacing developed LA dilation and decreased LVFS, but
the DDDR-l group with 17% proportion of RV pacing
developed LA dilation but no change in LVFS. Atrial
fibrillation, which was diagnosed on the basis of a 12-lead
electrocardiogram at planned follow-up visits, was more
common in the DDDR group, indicating that ventricular
desynchronization promotes atrial fibrillation, probably by
causing LA dilation.
Comparison of the AAIR versus DDDR trial with
VVI(R) versus DDD(R) trials. The lack of ventricular
desynchronization in the AAI mode may explain the re-
markable benefit of AAI compared with VVI pacing ob-
tained by the Danish group in patients with the sick sinus
syndrome, in a protocol where the investigation focused
only on the role of AV synchrony (2). In contrast, studies
comparing the DDD(R) with the VVI(R) modes of pacing
have yielded less impressive and somewhat inconsistent
results, probably because the benefit of AV synchrony was
attenuated by the depressant effect of ventricular desynchro-
nization in patients using the DDD(R) mode (3,4).
Impact of ventricular desynchronization. The results of
the AAIR versus DDDR study are in accordance with the
recent data from the Dual Chamber and VVI Implantable
Defibrillator (DAVID) and Mode Selection Trial (MOST)
trials, where the end point was hospitalization for congestive
heart failure (CHF) (5–8). Sequential LV function was not
evaluated in these two trials. The DAVID trial compared
the clinical effectiveness of dual-chamber implantable
cardioverter-difibrillators (ICDs) programmed to the
DDDR pacing mode at 70 beats/min versus the VVI mode
at 40 beats/min (5). The AV delay was programmed
according to the clinical judgment of the investigators and
was commonly set at 180 ms, thereby favoring ventricular
pacing in the majority of patients. The study revealed a
strong trend toward higher mortality and hospitalization for
new or worsened CHF in the DDDR group (with nearly
60% of ventricular beats being paced). The DAVID study
suggested that unnecessary RV apical pacing delivered as
part of the DDDR arm produced ventricular desynchroni-
zation with impaired LV hemodynamic performance that
was ultimately harmful. The VVI group fared better because
the programmed rate of 40 beats/min minimized RV apical
pacing (with 1% of ventricular beats being paced). The
depression of LV function by RV apical pacing may be more
important in ICD patients with poor LV function and/or a
history of heart failure. The MOST study also demon-
strated an association between the percentage of RV pacing
in the DDDR mode (with maintenance of AV synchrony)
and CHF in patients with sick sinus syndrome and a QRS
duration 120 ms (7,8). The harmful consequences of RV
pacing in the MOST trial also appeared related to non-
physiologic LV contraction. A cumulative percentage of the
ventricular pacing index 10% was associated with lower
rates of CHF hospital admissions, and an index 90% was
associated with higher rates of hospitalization for CHF. For
DDDR pacing, the risk of CHF increased linearly until the
aforementioned percentage index reached 60%, and then it
formed a plateau. As in the study by Nielsen et al. (1), the
MOST study found a correlation between the cumulative
percentage of ventricular pacing index and the development
of atrial fibrillation (8). Interestingly, in the Multicenter
Automatic Defibrillator Trial II (MADIT II) study, in
which ICD programming was not standardized, the devel-
opment of new or worsened CHF was more common in the
ICD arm (19.9%) compared with the conventionally treated
patients (14.9%) (9). The higher incidence of CHF in the
ICD group was in all likelihood due to ventricular desyn-
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chronization rather than myocardial injury from ICD
shocks.
Mitral regurgitation induced by ventricular desynchron-
ization. Ventricular desynchronization itself may occasion-
ally cause severe mitral regurgitation that may precipitate
atrial fibrillation and CHF. Left ventricular contraction
initiated by apical RV pacing alters papillary muscle func-
tion, with resultant derangement of the time sequence of
activation of the mitral valve apparatus. Mitral annular
movement, which influences mitral valve function, is also
affected by LV dyssynchrony. Pacemaker-induced mitral
regurgitation may be largely reversible or attenuated in
many cases by restoration of LV synchrony either by
spontaneous beats or LV/biventricular pacing, thus avoiding
mitral valve replacement, even in patients with a normal
ejection fraction (10,11).
Are the abnormalities induced by long-term ventricular
desynchronization reversible? Long-term, nonphysiologic
or RV pacing in dogs induces adverse cellular changes with
myofibrillar disarray, asymmetric myocardial hypertrophy,
and LV dilation (12–14). The reversibility of these changes
has not been studied. In humans, RV pacing produces
alterations in local myocardial blood flow that are more
pronounced during pacing of the RV apex than of the
outflow tract (15,16). Furthermore, after 18 months of
long-term stimulation, RV apical pacing, but not RV
outflow tract pacing, was found to depress the LV ejection
fraction (16). Nielsen et al. (17) also found reversible
alterations in regional myocardial blood flow upon switch-
ing temporarily from long-term RV apical pacing to the
AAI mode, suggesting that perfusion defects are related to
the altered pattern of ventricular depolarization. In their
myocardial blood flow study, Nielsen et al. (17) pro-
grammed their DDD patients (the same as those in the
DDDR-s group) to the AAI mode at the time of myocar-
dial blood flow measurement. The LV ejection fraction
measured during temporary AAI pacing was significantly
higher than that during DDD-s pacing and not different
from the LV ejection fraction measured at the time of
implantation about 22 months previously. These intriguing
results were not reproduced in the AAIR versus DDDR
study of Nielsen et al. (1), where the DDDR-s mode was
programmed to the AAI mode and an echocardiographic
comparison was performed only 5 min after programming
the AAI mode. The very short duration of pacing in the
AAI mode may probably explain the persistence of LA and
LV abnormalities in the AAI mode, so that no firm
conclusions can be drawn from these observations. Obvi-
ously, more work is needed to determine the reversibility of
the LA and LV abnormalities engendered by ventricular
desynchronization. The reversibility of mechanical LA re-
modeling caused by long-term VVI pacing upon the estab-
lishment of DDD pacing (18) suggests that AAI(R) pacing
for a longer time than 5 min might also have reversed
mechanical LA remodeling associated with DDDR pacing
in the AAIR versus DDDR trial (1).
Is the long-term benefit of AAIR pacing worth the small
risk of AV block? The development of spontaneous, com-
plete heart block during AAI pacing in carefully selected
patients is unusual and generally not considered a poten-
tially life-threatening situation in reports advocating the use
of single- lead atrial pacing. Although complete AV block
during AAI(R) pacing often seems to be tolerated without
a ventricular lead in place, it can obviously be devastating,
especially when accompanied by syncope. The incidence of
syncope related to AV block is not negligible during AAI
pacing, and its occurrence, no matter how infrequent, is
difficult to accept considering that the fundamental purpose
of antibradycardia pacing is to prevent it.
The best of both worlds. Perhaps it is time to reconsider
the generally held view in the U.S. that AAIR as a primary
mode of pacing is obsolete and to examine how the risk of
AV block can be eliminated. Theoretically, in patients with
normal AV conduction, functional AAIR pacing should
occur with virtual elimination of ventricular pacing by using
the DDDR mode with a long AV delay (250 to 300 ms).
The AAIR versus DDDR trial showed this was not possi-
ble, at least with an AV delay of 250 ms (17% RV pacing),
confirming data from a small number of studies that used
AV delays as long as 300 ms or AV search hysteresis
(1,19–21). The causes of the 17% incidence of ventricular
pacing in the DDDR-l group was not studied and may
involve many mechanism such as ventricular fusion and
pseudofusion beats. Such data would help in the design of
pacemakers capable of withholding RV stimulation in a
variety of circumstances where pacing is not warranted.
In 1997, Andersen (22), an obvious proponent of AAI
pacing, wrote that “in the future, another technical solution
may be available with modern units, i.e., automatic mode
switching from AAI to DDD. . .” for patients with sick
sinus syndrome. Such devices became available some time
ago, but their performance in minimizing RV pacing has
not been studied in detail. The results of the AAIR versus
DDDR, DAVID, and MOST trials have highlighted the
importance of developing sophisticated pacemakers and
ICDs capable of minimizing RV pacing more efficiently
than the present devices (which work primarily on the basis
of a relatively long AV delay) in patients without AV block
(1,5–8). With such new devices, we will be able to give
patients without AV block or bundle branch block the best
of both worlds—almost continuous physiologic ventricular
depolarization through the His-Purkinje system without the
risk of AV block.
Finally, the results of the AAIR versus DDDR, DAVID,
and MOST trials should be considered as a wake-up call to
investigate the use cardiac resynchronization not for the
treatment of existing LV dyssynchrony in patients with
CHF and left bundle branch block but for “primary preven-
tion” in the first place in selected patients who require
ventricular pacing most of the time.
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